AU2020901334A0 - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- AU2020901334A0 AU2020901334A0 AU2020901334A AU2020901334A AU2020901334A0 AU 2020901334 A0 AU2020901334 A0 AU 2020901334A0 AU 2020901334 A AU2020901334 A AU 2020901334A AU 2020901334 A AU2020901334 A AU 2020901334A AU 2020901334 A0 AU2020901334 A0 AU 2020901334A0
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202180045562.6A CN117202929A (en) | 2020-04-28 | 2021-04-28 | Human cytomegalovirus multi-epitope vaccine composition |
BR112022021769A BR112022021769A2 (en) | 2020-04-28 | 2021-04-28 | HUMAN CYTOMEGALOVIRUS POLYEpitope VACCINE COMPOSITION |
PCT/AU2021/050385 WO2021217206A1 (en) | 2020-04-28 | 2021-04-28 | Human cytomegalovirus polyepitope vaccine composition |
JP2022564217A JP2023526766A (en) | 2020-04-28 | 2021-04-28 | Human cytomegalovirus polyepitope vaccine composition |
AU2021263337A AU2021263337A1 (en) | 2020-04-28 | 2021-04-28 | Human cytomegalovirus polyepitope vaccine composition |
US17/921,945 US20230173061A1 (en) | 2020-04-28 | 2021-04-28 | Human cytomegalovirus polyepitope vaccine composition |
MX2022013490A MX2022013490A (en) | 2020-04-28 | 2021-04-28 | Human cytomegalovirus polyepitope vaccine composition. |
IL297736A IL297736A (en) | 2020-04-28 | 2021-04-28 | Human cytomegalovirus polyepitope vaccine composition |
KR1020227040909A KR20230005899A (en) | 2020-04-28 | 2021-04-28 | Human cytomegalovirus polyepitope vaccine composition |
EP21796930.2A EP4143208A4 (en) | 2020-04-28 | 2021-04-28 | Human cytomegalovirus polyepitope vaccine composition |
CA3177020A CA3177020A1 (en) | 2020-04-28 | 2021-04-28 | Human cytomegalovirus polyepitope vaccine composition |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2020901334A0 true AU2020901334A0 (en) | 2020-05-14 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202019241D0 (en) | Pharmaceutical composition | |
EP4148096A4 (en) | Composition | |
IL304290A (en) | Pharmaceutical composition | |
EP4015001A4 (en) | Oral pharmaceutical composition | |
EP3964264A4 (en) | Novel pharmaceutical composition | |
EP3984549A4 (en) | Medicinal composition | |
EP3949952A4 (en) | Medicinal composition | |
EP3914234A4 (en) | Pharmaceutical compositions | |
EP3950058A4 (en) | Pharmaceutical composition having favorable stability | |
EP4005556A4 (en) | Pharmaceutical composition comprising udenafil | |
EP3920909A4 (en) | Pharmaceutical compositions comprising meloxicam | |
EP4129276A4 (en) | Pharmaceutical composition | |
AU2020901334A0 (en) | Pharmaceutical composition | |
AU2023901609A0 (en) | Pharmaceutical composition | |
EP4176868A4 (en) | Stable pharmaceutical composition | |
EP4032535A4 (en) | Pharmaceutical composition | |
EP3991750A4 (en) | Pharmaceutical composition | |
EP3957318A4 (en) | Pharmaceutical composition | |
AU2020903781A0 (en) | Pharmaceutical formulations | |
AU2020903780A0 (en) | Pharmaceutical formulations | |
GB202208464D0 (en) | Pharmaceutical composition | |
AU2022416581A1 (en) | Composition | |
GB202109271D0 (en) | Pharmaceutical composition | |
GB202108387D0 (en) | Pharmaceutical composition | |
GB202107518D0 (en) | Pharmaceutical composition |